...
首页> 外文期刊>Cancer immunology research. >Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow
【24h】

Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow

机译:多发性骨髓瘤骨髓中不同B族谱系的克隆膨胀与相互关联

获取原文
获取原文并翻译 | 示例
           

摘要

Multiple myeloma is characterized by the clonal expansion of malignant plasma cells in the bone marrow. But the phenotypic diversity and the contribution of less predominant B-lineage clones to the biology of this disease have been controversial. Here, we asked whether cells bearing the dominant multiple myeloma immunoglobulin rearrangement occupy phenotypic compartments other than that of plasma cells. To accomplish this, we combined 13-parameter FACS index sorting and t-Stochastic Neighbor Embedding (t-SNE) visualization with high-throughput single-cell immunoglobulin sequencing to track selected B-lineage clones across different stages of human B-cell development. As expected, the predominant clones preferentially mapped to aberrant plasma cell compartments, albeit phenotypically altered from wild type. Interestingly, up to 1.2% of cells of the predominant clones colocalized with B-lineage cells of a normal phenotype. In addition, minor clones with distinct immunoglobulin sequences were detected in up to 9% of sequenced cells, but only 2 out of 12 of these clones showed aberrant immune phenotypes. The majority of these minor clones showed intraclonal silent nucleotide differences within the CDR3s and varying frequencies of somatic mutations in the immunoglobulin genes. Therefore, the phenotypic range ofmultiplemyeloma cells in the bone marrow is not confined to aberrant-phenotype plasma cells but extends to low frequencies of normal-phenotype B cells, in line with the recently reported success of B cell-targeting cellular therapies in some patients. The majority of minor clones result from parallel nonmalignant expansion. (C) 2017 AACR.
机译:多种骨髓瘤的特征在于骨髓中恶性血浆细胞的克隆膨胀。但表型多样性和较少的B族血管克隆对这种疾病生物学的贡献一直存在争议。在此,我们询问细胞是否承载显性多发性多发性骨髓瘤免疫球蛋白重排占血浆细胞以外的表型隔室。为了实现这一点,我们将13个参数FACS指数分选和T-STOCOCHASE邻居嵌入(T-SNE)可视化与高通量单细胞免疫球蛋白测序进行嵌入跨越人B细胞发育的不同阶段的选定的B型克隆。如预期的那样,优先映射到异常等离子体细胞室的主要克隆,尽管从野生型改变了表型。有趣的是,高达克隆的主要克隆的细胞高达1.2%的细胞与正常表型的B族谱系细胞分开。此外,在高达9%的测序细胞中检测到具有不同免疫球蛋白序列的次要克隆,但这些克隆中只有2个中只有2种显示异常的免疫表型。这些次要克隆的大多数显示CDR3S内的胞内静音核苷酸差异以及免疫球蛋白基因中的体细胞突变的不同频率。因此,骨髓中的multiplemeloma细胞的表型范围不限于异常表型浆细胞,但延伸到正常表型B细胞的低频,这与最近报道的B细胞靶向细胞疗法的成功均有一些患者。大多数次要克隆是由平行的非膨胀膨胀产生的。 (c)2017年AACR。

著录项

  • 来源
    《Cancer immunology research.》 |2017年第9期|共11页
  • 作者单位

    Stanford Univ Dept Microbiol &

    Immunol Stanford CA 94305 USA;

    Stanford Univ Dept Microbiol &

    Immunol Stanford CA 94305 USA;

    Charite Dept Hematol Oncol &

    Tumor Immunol Berlin Germany;

    Stanford Univ Div Hematol Dept Med Stanford CA 94305 USA;

    Stanford Univ Dept Microbiol &

    Immunol Stanford CA 94305 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号